You are here

Article Text

Article menu
Download PDFPDF
Health services research
Research Letter
Cross-sectional study of patients tested for STIs using molecular methods in Brazil
  1. Feliciana Lage Marinho,
  2. Danielle Zauli
  1. Research & Development Division, Hermes Pardini Institute, Vespasiano, Minas Gerais, Brazil
  1. Correspondence to Dr Danielle Zauli, Hermes Pardini Institute, 33200-000 Belo Horizonte, Brazil; danielle.zauli{at}hermespardini.com.br

https://doi.org/10.1136/sextrans-2019-054362

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    STIs represent an important global public health problem due to the high morbidity and mortality associated with them, and also due to the involvement of more than one pathogen, which makes the diagnosis challenging and increases the cost associated with the treatment of these infections.1–3 According to WHO, more than 1 million STI cases are reported every day worldwide.4 In Brazil, it is estimated that there are 10 to 12 million new cases annually.2 More than 30 different micro-organisms have been found to cause STIs, and some of them are linked with higher incidence such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Ureaplasma urealyticum (UU), Mycoplasma …

    View Full Text

    Footnotes

    • Handling editor Anna Maria Geretti

    • Contributors Contributors FLM and DZ collaborated in the design, conducting and writing of the manuscript.

    • Funding This study was funded by Hermes Pardini Institute.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.